Jiangsu Canopus Wisdom Medical Technology Co.,Ltd. (SHE:301290)
China flag China · Delayed Price · Currency is CNY
28.09
-0.26 (-0.92%)
At close: Sep 4, 2026

SHE:301290 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Operating Revenue
380.75380.72430.47430.5440.73442.57
Other Revenue
3.756.774.993.231.373.93
384.5387.49435.46433.73442.1446.5
Revenue Growth
-5.11%-11.02%0.40%-1.89%-0.98%19.25%
Cost of Revenue
197.23202.1221.08225.86210.6195.33
Gross Profit
187.27185.39214.38207.88231.5251.17
Selling, General & Admin
109.21110.17112.72106.6293.08104.58
Research & Development
22.3120.9722.4327.1124.2120.67
Other Operating Expenses
4.934.595.182.654.393.14
Operating Expenses
137.06134.99140.77135.94124.56128.17
Operating Income
50.2150.3973.671.94106.94123
Interest Expense
-0.76-1.27-0.34-0.06-0.13-0.11
Interest & Investment Income
24.3225.839.416.255.282.4
Currency Exchange Gain (Loss)
-0.25-0.51-0.14-0.020.49-0.1
Other Non Operating Income (Expenses)
-0.89-0.14-0.1-0.05-0.28-0.34
EBT Excluding Unusual Items
72.6374.26112.4288.05112.3124.85
Impairment of Goodwill
-99.72-99.72----
Gain (Loss) on Sale of Investments
8.993.01-713.690.5-
Gain (Loss) on Sale of Assets
0-0.04-0.09-0.59-0.43-0.25
Asset Writedown
-5.61-5.63----
Other Unusual Items
0.850.549.7315.917.445.33
Pretax Income
-22.86-27.58115.06117.06119.82129.93
Income Tax Expense
13.3912.3218.1717.1816.118.86
Earnings From Continuing Operations
-36.26-39.996.8999.88103.72111.07
Minority Interest in Earnings
2.161.960.53-2.66-1.21-0.82
Net Income
-34.1-37.9497.4297.22102.51110.25
Net Income to Common
-34.1-37.9497.4297.22102.51110.25
Net Income Growth
--0.21%-5.15%-7.03%38.33%
Shares Outstanding (Basic)
98100991007775
Shares Outstanding (Diluted)
98100991007775
Shares Change
-2.11%0.43%-0.81%30.05%2.76%10.45%
EPS (Basic)
-0.35-0.380.980.971.331.47
EPS (Diluted)
-0.35-0.380.980.971.331.47
EPS Growth
--1.03%-27.07%-9.52%25.64%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
44.2738.0310.5451.6820.2867.78
Free Cash Flow Per Share
0.450.380.110.520.260.90
Dividend Per Share
0.3000.3000.6000.6000.500-
Dividend Growth
-50.00%-50.00%0%20.00%--
Gross Margin
48.70%47.84%49.23%47.93%52.36%56.25%
Operating Margin
13.06%13.00%16.90%16.59%24.19%27.55%
Profit Margin
-8.87%-9.79%22.37%22.41%23.19%24.69%
Free Cash Flow Margin
11.51%9.81%2.42%11.91%4.59%15.18%
EBITDA
91.1691.52115.76109.58141.18150.64
EBITDA Margin
23.71%23.62%26.58%25.26%31.93%33.74%
D&A For EBITDA
40.9541.1242.1537.6434.2427.64
EBIT
50.2150.3973.671.94106.94123
EBIT Margin
13.06%13.00%16.90%16.59%24.19%27.55%
Effective Tax Rate
--15.79%14.68%13.44%14.52%
Revenue as Reported
204.2387.49435.46433.73442.1446.5
Advertising Expenses
-1.642.071.871.342.48